Manfred Lauchart

As head of program & portfolio management at the Bill & Melinda Gates Medical Research Institute, Manfred Lauchart, Ph.D., ensures the delivery of highly-needed medicinal products by driving strategic planning and execution of development programs.

Manfred has extensive product development experience in Fortune 500 Life Science companies, business units, and small biotech start-ups, leading international and cross-functional teams to develop, launch, and sustain life-saving biopharmaceutical and medical device products. Prior to joining Gates MRI, Manfred served as vice president and head of program management organization at Intarcia Therapeutics, where he drove planning and execution of the pipeline portfolio from 2017 to 2020. Prior to Intarcia, he served as an independent consultant providing and implementing program management solutions for life science companies. As senior director of R&D, head of business operations for global clinical development, and chief of staff at Baxalta, he optimized business processes and secured compliance with existing regulatory requests as well as new R&D standards. From 2003 to 2015, Manfred served as senior director program management office R&D at Baxter Bioscience and Baxter Medical Products divisions, leading international teams in the U.S., EU, and Asia advancing vaccine, pharmaceutical, and medical device development programs through all stages of product development to licensure and product launch.

Manfred earned his Master of Science in Microbiology and Immunology and his Ph.D. from the University of Vienna, Austria. He later earned a Master of Management degree from Malik Management Centre in St. Gallen, Switzerland.